THC logo

THC Stock

StockStock
ISIN: CA87243W1032
Ticker: THC
CA87243W1032
THC

Price

Frequently asked questions

What is THC's market capitalization?

The market capitalization of THC is $2.34M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for THC?

THC's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.016. EPS indicates the company's profitability on a per-share basis.

What is THC's revenue over the trailing twelve months?

Over the trailing twelve months, THC reported a revenue of $2.04M.

What is the EBITDA for THC?

THC's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$1.56M. EBITDA measures the company's overall financial performance.

What is the free cash flow of THC?

THC has a free cash flow of -$255.42K. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of THC's stock?

The 5-year beta for THC is 0.45. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does THC have, and what sector and industry does it belong to?

THC employs approximately 35 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of THC's shares?

The free float of THC is 116.35M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$2.34M

5Y beta

 
0.45

EPS (TTM)

 
-$0.016

Free Float

 
116.35M

Revenue (TTM)

 
$2.04M

EBITDA (TTM)

 
-$1.56M

Free Cashflow (TTM)

 
-$255.42K

Pricing

52W span
$0.007356$0.0219

Information

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.

35

Biotechnology & Drugs

Health Care

Identifier

ISIN

CA87243W1032

Primary Ticker

THC
Join the conversation